{"nctId":"NCT03530800","briefTitle":"Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors","startDateStruct":{"date":"2018-10-01","type":"ACTUAL"},"conditions":["Trichotillomania","Skin-Picking"],"count":50,"armGroups":[{"label":"Dronabinol","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Dronabinol"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Dronabinol","otherNames":["Marinol"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* current DSM-5 trichotillomania\n* ability to understand and sign the consent form\n\nExclusion Criteria:\n\n* Unstable Medical illness based on history of clinically significant abnormalities on baseline physical examination\n* Current pregnancy or lactation, or inadequate contraception in women of childbearing potential\n* Subjects considered an immediate suicide risk based on the Columbia Suicide Severity Rating Scale (C-SSRS) (www.cssrs.columbia.edu/docs)\n* Past 12-month DSM-5 psychiatric disorder other than trichotillomania\n* Illegal substance use based on urine toxicology screening\n* Use of any other psychotropic medication (except a PRN hypnotic)\n* Previous treatment with dronabinol\n* Cognitive impairment that interferes with the capacity to understand and self administer medication or provide written informed consent","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"NIMH Trichotillomania Symptom Severity Scale (NIMH-TSS)","description":"The entire study lasts 10 weeks. Every two weeks subjects will take the NIMH-TSS. The change in scores from baseline to after 10 weeks will be assessed. The scale itself assesses severity of trichotillomania symptoms. The NIMH-TSS score ranges from 0 to 20, with 0 being no symptoms and 20 being the most severe.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.38","spread":"3.15"},{"groupId":"OG001","value":"10.63","spread":"3.42"}]}]}]},{"type":"PRIMARY","title":"Skin Picking Symptom Assessment Scale (SP-SAS)","description":"The entire study lasts 10 weeks. Every two weeks subjects will take the SP-SAS. The change in scores from baseline to after 10 weeks will be assessed. The scale itself assesses severity of skin-picking symptoms. The SP-SAS score ranges from 0 to 48, with 0 being no symptoms and 48 being the most severe.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.44","spread":"9.46"},{"groupId":"OG001","value":"28.5","spread":"4.23"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":25},"commonTop":["Sedation","Light headed/dizzy","Cognitive blunting, attentional problems","Dry mouth","High (easy laughing, elation, heightened awareness)"]}}}